{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:17:56Z","timestamp":1778869076855,"version":"3.51.4"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05910-z","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:33:02Z","timestamp":1778862782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ginsenosides for Multi-target Intervention in Alzheimer\u2019s Disease: Current Evidence, Challenges, and Future Directions"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4443-628X","authenticated-orcid":false,"given":"Ghaleb","family":"Oriquat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7723-7504","authenticated-orcid":false,"given":"Afaq Mahdi","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malathi","family":"H.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israa Abdulhameed","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0424-0875","authenticated-orcid":false,"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vimal","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilakshan","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Kumar-Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"5910_CR1","doi-asserted-by":"publisher","unstructured":"Khalid D, Afroz A, Ismail H, Rashid U, Hadri SH (2025) Key elements involved in Alzheimer\u2019s disease progression.\u00a0Central Nervous System Agents in Medicinal Chemistry. Advance online publication. https:\/\/doi.org\/10.2174\/0118715249388578250827072156","DOI":"10.2174\/0118715249388578250827072156"},{"issue":"21","key":"5910_CR2","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","volume":"15","author":"R Tenchov","year":"2024","unstructured":"Tenchov R, Sasso JM, Zhou QA (2024) Alzheimer\u2019s disease: exploring the landscape of cognitive decline. ACS Chem Neurosci 15(21):3800\u20133827","journal-title":"ACS Chem Neurosci"},{"key":"5910_CR3","doi-asserted-by":"publisher","DOI":"10.1590\/1980-5764-dn-2024-vr01","volume":"18","author":"E Engelhardt","year":"2024","unstructured":"Engelhardt E, Resende EPF, Gomes KB (2024) Physiopathological mechanisms underlying Alzheimer\u2019s disease: a narrative review. Dement Neuropsychol 18:e2024VR01","journal-title":"Dement Neuropsychol"},{"issue":"10","key":"5910_CR4","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H et al (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26(10):5481\u20135503","journal-title":"Mol Psychiatry"},{"key":"5910_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165858","author":"MS Uddin","year":"2020","unstructured":"Uddin MS et al (2020) Revisiting the amyloid cascade hypothesis: from anti-A\u03b2 therapeutics to auspicious new ways for Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21165858","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5910_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14(1):32","journal-title":"Mol Neurodegener"},{"key":"5910_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010131","author":"DC Miculas","year":"2022","unstructured":"Miculas DC et al (2022) Pharmacotherapy evolution in Alzheimer\u2019s disease: current framework and relevant directions. Cells. https:\/\/doi.org\/10.3390\/cells12010131","journal-title":"Cells"},{"issue":"4","key":"5910_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14638","volume":"104","author":"YP Singh","year":"2024","unstructured":"Singh YP, Kumar H (2024) Recent advances in medicinal chemistry of memantine against Alzheimer\u2019s disease. Chem Biol Drug Des 104(4):e14638","journal-title":"Chem Biol Drug Des"},{"issue":"s1","key":"5910_CR9","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.3233\/JAD-240479","volume":"101","author":"MK Sun","year":"2024","unstructured":"Sun MK, Alkon DL (2024) Treating Alzheimer\u2019s disease: focusing on neurodegenerative consequences. J Alzheimers Dis 101(s1):S263-s274","journal-title":"J Alzheimers Dis"},{"key":"5910_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gerinurse.2025.05.010","volume":"64","author":"Z Sadruddin","year":"2025","unstructured":"Sadruddin Z et al (2025) Anti-amyloid immunotherapies for Alzheimer\u2019s disease: administration, side effects, and overall framework. Geriatr Nurs 64:103371","journal-title":"Geriatr Nurs"},{"issue":"1","key":"5910_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","volume":"14","author":"B-H Kim","year":"2025","unstructured":"Kim B-H et al (2025) Second-generation anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: current landscape and future perspectives. Transl Neurodegener 14(1):6","journal-title":"Transl Neurodegener"},{"issue":"1","key":"5910_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","volume":"38","author":"J Cummings","year":"2024","unstructured":"Cummings J et al (2024) Anti-amyloid monoclonal antibodies for the treatment of Alzheimer\u2019s disease. BioDrugs 38(1):5\u201322","journal-title":"BioDrugs"},{"issue":"3","key":"5910_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00570","volume":"22","author":"JL Cummings","year":"2025","unstructured":"Cummings JL (2025) Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer\u2019s disease: strategies and research directions. Neurotherapeutics 22(3):e00570","journal-title":"Neurotherapeutics"},{"issue":"1","key":"5910_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jgr.2023.08.003","volume":"48","author":"MY Lee","year":"2024","unstructured":"Lee MY, Kim M (2024) Effects of red ginseng on neuroinflammation in neurodegenerative diseases. J Ginseng Res 48(1):20\u201330","journal-title":"J Ginseng Res"},{"issue":"9","key":"5910_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/diseases13090285","volume":"13","author":"E Frazer","year":"2025","unstructured":"Frazer E et al (2025) A review of the mechanisms and risks of Panax ginseng in the treatment of alcohol use disorder. Diseases 13(9):285","journal-title":"Diseases"},{"issue":"4","key":"5910_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jgr.2025.03.011","volume":"49","author":"J Hwang","year":"2025","unstructured":"Hwang J et al (2025) Panax ginseng: a modulator of amyloid, tau pathology, and cognitive function in Alzheimer\u2019s disease. J Ginseng Res 49(4):348\u2013355","journal-title":"J Ginseng Res"},{"issue":"12","key":"5910_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20123030","volume":"20","author":"SJ Shin","year":"2019","unstructured":"Shin SJ et al (2019) Red ginseng attenuates A\u03b2-induced mitochondrial dysfunction and A\u03b2-mediated pathology in an animal model of Alzheimer\u2019s disease. Int J Mol Sci 20(12):3030","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5910_CR18","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1016\/j.apsb.2023.06.009","volume":"13","author":"J Moreira","year":"2023","unstructured":"Moreira J et al (2023) The neuroprotective effect of traditional Chinese medicinal plants\u2014a critical review. Acta Pharm Sin B 13(8):3208\u20133237","journal-title":"Acta Pharm Sin B"},{"issue":"21","key":"5910_CR19","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1021\/acs.jafc.1c01231","volume":"69","author":"MY Ali","year":"2021","unstructured":"Ali MY et al (2021) Inhibition of angiotensin-I converting enzyme by ginsenosides: structure\u2013activity relationships and inhibitory mechanism. J Agric Food Chem 69(21):6073\u20136086","journal-title":"J Agric Food Chem"},{"issue":"8","key":"5910_CR20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2174\/0115734064295063240422100615","volume":"20","author":"M Kumar","year":"2024","unstructured":"Kumar M et al (2024) PPARs (peroxisome proliferator-activated receptors) and their agonists in Alzheimer\u2019s disease. Med Chem 20(8):781\u2013798","journal-title":"Med Chem"},{"issue":"1","key":"5910_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2011.11.039","volume":"675","author":"L-M Chen","year":"2012","unstructured":"Chen L-M et al (2012) Ginsenoside Rg1 attenuates \u03b2-amyloid generation via suppressing PPAR\u03b3-regulated BACE1 activity in N2a-APP695 cells. Eur J Pharmacol 675(1):15\u201321","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"5910_CR22","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1089\/ars.2019.7763","volume":"32","author":"Y Peng","year":"2020","unstructured":"Peng Y et al (2020) Central and peripheral metabolic defects contribute to the pathogenesis of Alzheimer\u2019s disease: targeting mitochondria for diagnosis and prevention. Antioxid Redox Signal 32(16):1188\u20131236","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"5910_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/life12010058","volume":"12","author":"Y-J Yun","year":"2022","unstructured":"Yun Y-J et al (2022) Ginsenoside F1 protects the brain against amyloid beta-induced toxicity by regulating IDE and NEP. Life 12(1):58","journal-title":"Life"},{"issue":"2","key":"5910_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3233\/JAD-190026","volume":"71","author":"Q Quan","year":"2019","unstructured":"Quan Q et al (2019) CDK5 participates in amyloid-\u03b2 production by regulating PPAR\u03b3 phosphorylation in primary rat hippocampal neurons. J Alzheimers Dis 71(2):443\u2013460","journal-title":"J Alzheimers Dis"},{"key":"5910_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2015.03.071","volume":"758","author":"SK Jang","year":"2015","unstructured":"Jang SK et al (2015) An A\u03b242 uptake and degradation via Rg3 requires an activation of caveolin, clathrin and A\u03b2-degrading enzymes in microglia. Eur J Pharmacol 758:1\u201310","journal-title":"Eur J Pharmacol"},{"key":"5910_CR26","doi-asserted-by":"publisher","first-page":"254248232513418","DOI":"10.1177\/25424823251341870","volume":"9","author":"S Fakorede","year":"2025","unstructured":"Fakorede S et al (2025) Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer\u2019s disease. J Alzheimers Dis Rep 9:25424823251341870","journal-title":"J Alzheimers Dis Rep"},{"key":"5910_CR27","doi-asserted-by":"publisher","first-page":"1707688","DOI":"10.3389\/fphar.2026.1707688","volume":"17","author":"M Zhao","year":"2026","unstructured":"Zhao M, Qu Y, Zhang S, Zhang M, Wang H, Yang Y, Xue G, Hou X, Yan X (2026) Multi-target intervention mechanisms and prospects of the traditional Chinese medicine Scutellaria baicalensis Georgi in Alzheimer\u2019s disease. Front Pharmacol 17:1707688. https:\/\/doi.org\/10.3389\/fphar.2026.1707688","journal-title":"Front Pharmacol"},{"issue":"1","key":"5910_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12974-018-1250-1","volume":"15","author":"Y Fang","year":"2018","unstructured":"Fang Y et al (2018) The adhesion and migration of microglia to \u03b2-amyloid (A\u03b2) is decreased with aging and inhibited by Nogo\/NgR pathway. J Neuroinflammation 15(1):210","journal-title":"J Neuroinflammation"},{"key":"5910_CR29","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S380612","author":"H Yan","year":"2023","unstructured":"Yan H, Feng L, Li M (2023) The role of traditional Chinese medicine natural products in \u03b2-amyloid deposition and tau protein hyperphosphorylation in Alzheimer\u2019s disease. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/DDDT.S380612","journal-title":"Drug Des Devel Ther"},{"issue":"8","key":"5910_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202200138","volume":"45","author":"A Cario","year":"2023","unstructured":"Cario A, Berger CL (2023) Tau, microtubule dynamics, and axonal transport: new paradigms for neurodegenerative disease. Bioessays 45(8):e2200138","journal-title":"Bioessays"},{"issue":"1","key":"5910_CR31","first-page":"4485957","volume":"2021","author":"L Li","year":"2021","unstructured":"Li L et al (2021) Ginsenoside Rd attenuates tau phosphorylation in olfactory bulb, spinal cord, and telencephalon by regulating glycogen synthase kinase 3\u03b2 and cyclin\u2010dependent kinase 5. Evid Based Complement Altern Med 2021(1):4485957","journal-title":"Evid Based Complement Altern Med"},{"issue":"8","key":"5910_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14885","volume":"30","author":"Z Zhao","year":"2024","unstructured":"Zhao Z et al (2024) Natural compounds from herbs and nutraceuticals as glycogen synthase kinase-3\u03b2 inhibitors in Alzheimer\u2019s disease treatment. CNS Neurosci Ther 30(8):e14885","journal-title":"CNS Neurosci Ther"},{"key":"5910_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/978-981-99-2657-2_14","volume-title":"deciphering drug targets for Alzheimer\u2019s disease","author":"G Shareena","year":"2023","unstructured":"Shareena G, Kumar D (2023) Exploring the role of tau proteins in Alzheimer\u2019s disease from typical functioning MAPs to aberrant fibrillary deposits in the brain. deciphering drug targets for Alzheimer\u2019s disease. Springer, pp 321\u2013349"},{"key":"5910_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ibneur.2025.05.007","volume":"18","author":"C Xie","year":"2025","unstructured":"Xie C et al (2025) Ginsenoside C-K inhibits A\u03b2 oligomer-induced Alzheimer\u2019s disease pathology progression by regulating microglia-neuron interactions. IBRO Neurosci Rep 18:783\u2013793","journal-title":"IBRO Neurosci Rep"},{"issue":"15","key":"5910_CR35","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.3390\/molecules28155716","volume":"28","author":"M Shan","year":"2023","unstructured":"Shan M et al (2023) American ginseng for the treatment of Alzheimer\u2019s disease: a review. Molecules 28(15):5716","journal-title":"Molecules"},{"key":"5910_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.590896","volume":"13","author":"Y Soeda","year":"2020","unstructured":"Soeda Y, Takashima A (2020) New insights into drug discovery targeting tau protein. Front Mol Neurosci 13:590896","journal-title":"Front Mol Neurosci"},{"key":"5910_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.bbr.2012.11.037","volume":"241","author":"H-h Zhao","year":"2013","unstructured":"Zhao H-h et al (2013) Involvement of GSK3 and PP2A in ginsenoside Rb1\u2019s attenuation of aluminum-induced tau hyperphosphorylation. Behav Brain Res 241:228\u2013234","journal-title":"Behav Brain Res"},{"key":"5910_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/biom12071004","author":"BM Polster","year":"2022","unstructured":"Polster BM et al (2022) Calpain-independent intracellular protease activity is elevated in excitotoxic cortical neurons prior to delayed calcium deregulation and mitochondrial dysfunction. Biomolecules. https:\/\/doi.org\/10.3390\/biom12071004","journal-title":"Biomolecules"},{"key":"5910_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.nbd.2013.01.002","volume":"54","author":"L Li","year":"2013","unstructured":"Li L et al (2013) Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Neurobiol Dis 54:320\u2013328","journal-title":"Neurobiol Dis"},{"key":"5910_CR40","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3389\/fphar.2018.01503","volume":"9","author":"C Yang","year":"2018","unstructured":"Yang C, Deng L, Li W, Duan W, Zhang L, Wang X et al (2018) Cornel iridoid glycoside inhibits tau hyperphosphorylation via regulating cross-talk between GSK-3\u03b2 and PP2A signaling. Front Pharmacol 9:1503. https:\/\/doi.org\/10.3389\/fphar.2018.01503","journal-title":"Front Pharmacol"},{"issue":"3","key":"5910_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11596-021-2369-3","volume":"41","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021) Protective effect of hydroxysafflor yellow a against chronic mild stress-induced memory impairments by suppressing Tau phosphorylation in mice. Curr Med Sci 41(3):555\u2013564","journal-title":"Curr Med Sci"},{"issue":"1","key":"5910_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/fn.2025.156508","volume":"64","author":"Y Li","year":"2026","unstructured":"Li Y, Li S, Ma J, Zhao J, Ning N, Sun J (2026) The role of synaptic plasticity in Alzheimer\u2019s disease: from molecular mechanisms to therapeutic targets. Folia Neuropathol 64(1):1\u201311. https:\/\/doi.org\/10.5114\/fn.2025.156508","journal-title":"Folia Neuropathol"},{"issue":"4","key":"5910_CR43","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1113\/EP093221","volume":"111","author":"M Nourizadeh","year":"2026","unstructured":"Nourizadeh M et al (2026) Immunomodulatory effects of cathelicidin in the gut-brain axis: a novel link between mucosal immunity and neuroinflammation. Exp Physiol 111(4):1733\u20131745","journal-title":"Exp Physiol"},{"key":"5910_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1228679","volume":"11","author":"L Hu","year":"2023","unstructured":"Hu L et al (2023) Recent progress of nanomedicine in the treatment of Alzheimer\u2019s disease. Front Cell Dev Biol 11:1228679","journal-title":"Front Cell Dev Biol"},{"key":"5910_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1016559","volume":"15","author":"D Xie","year":"2022","unstructured":"Xie D et al (2022) The cellular model for Alzheimer\u2019s disease research: PC12 cells. Front Mol Neurosci 15:1016559","journal-title":"Front Mol Neurosci"},{"issue":"51","key":"5910_CR46","doi-asserted-by":"publisher","first-page":"47504","DOI":"10.1021\/acsomega.2c05609","volume":"7","author":"A Akhtar","year":"2022","unstructured":"Akhtar A et al (2022) Preclinical models for Alzheimer\u2019s disease: past, present, and future approaches. ACS Omega 7(51):47504\u201347517","journal-title":"ACS Omega"},{"issue":"3","key":"5910_CR47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jgr.2018.09.001","volume":"43","author":"SE Yu","year":"2019","unstructured":"Yu SE et al (2019) Ginsenosides: the need to move forward from bench to clinical trials. J Ginseng Res 43(3):361\u2013367","journal-title":"J Ginseng Res"},{"key":"5910_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.933149","volume":"13","author":"Z Shi","year":"2022","unstructured":"Shi Z, Zhong Z, Zhao Y, Wang Y, Zhang Q, Wang C et al (2022) Pharmacological effects of natural medicineginsenosides against Alzheimer\u2019s disease. Frontiers in Pharmacology 13:933149. https:\/\/doi.org\/10.3389\/fphar.2022.933149","journal-title":"Frontiers in Pharmacology"},{"issue":"17","key":"5910_CR49","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.3390\/molecules27175481","volume":"27","author":"A Skrzypczak-Wiercioch","year":"2022","unstructured":"Skrzypczak-Wiercioch A, Sa\u0142at K (2022) Lipopolysaccharide-induced model of neuroinflammation: mechanisms of action, research application and future directions for its use. Molecules 27(17):5481","journal-title":"Molecules"},{"issue":"6","key":"5910_CR50","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3892\/br.2013.153","volume":"1","author":"G Liu","year":"2013","unstructured":"Liu G et al (2013) Effects of apoptosis-related proteins caspase-3, Bax and Bcl-2 on cerebral ischemia rats. Biomed Rep 1(6):861\u2013867","journal-title":"Biomed Rep"},{"key":"5910_CR51","doi-asserted-by":"publisher","unstructured":"Ghahari AA, Safaeihavadaragh L, Nourizadeh M, Davari S, Safaei S, Zare F, Alkayyat S, Kamali Far E (2026) Neuroprotective roles of klotho: Molecular pathways and therapeutic implications for cognitive health in neurological and psychiatric diseases.\u00a0Experimental Physiology. Advance online publication.\u00a0https:\/\/doi.org\/10.1113\/EP093571","DOI":"10.1113\/EP093571"},{"issue":"4","key":"5910_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11011-025-01610-0","volume":"40","author":"F Mehrnoosh","year":"2025","unstructured":"Mehrnoosh F et al (2025) The role of Panax ginseng in neurodegenerative disorders: mechanisms, benefits, and future directions. Metab Brain Dis 40(4):183","journal-title":"Metab Brain Dis"},{"issue":"9","key":"5910_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70329","volume":"6","author":"S Mao","year":"2025","unstructured":"Mao S et al (2025) Activity and heterogeneity of astrocytes in neurological diseases: molecular mechanisms and therapeutic targets. MedComm 6(9):e70329","journal-title":"MedComm"},{"issue":"1","key":"5910_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41401-018-0154-z","volume":"40","author":"SF Chu","year":"2019","unstructured":"Chu SF et al (2019) Ginsenoside Rg1 protects against ischemic\/reperfusion-induced neuronal injury through miR-144\/Nrf2\/ARE pathway. Acta Pharmacol Sin 40(1):13\u201325","journal-title":"Acta Pharmacol Sin"},{"key":"5910_CR55","doi-asserted-by":"publisher","first-page":"1561082","DOI":"10.3389\/fphar.2025.1561082","volume":"16","author":"N Aktary","year":"2025","unstructured":"Aktary N, Rahimi M, Zarei M, Ghasemi F, Moradi S, Hosseinzadeh H et al (2025) Unveiling the therapeutic potential of natural products in Alzheimer\u2019s disease: Insights from in vitro, in vivo, and clinical studies. Front Pharmacol 16:1561082. https:\/\/doi.org\/10.3389\/fphar.2025.1561082","journal-title":"Front Pharmacol"},{"issue":"2","key":"5910_CR56","first-page":"717","volume":"43","author":"TZ Xu","year":"2019","unstructured":"Xu TZ et al (2019) Ginsenoside Rg1 protects against H2O2-induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro. Int J Mol Med 43(2):717\u2013726","journal-title":"Int J Mol Med"},{"issue":"12","key":"5910_CR57","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.2174\/1570159X22666240426091311","volume":"22","author":"MA Rahman","year":"2024","unstructured":"Rahman MA et al (2024) Drug target to alleviate mitochondrial dysfunctions in Alzheimer\u2019s disease: recent advances and therapeutic implications. Curr Neuropharmacol 22(12):1942\u20131959","journal-title":"Curr Neuropharmacol"},{"key":"5910_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1575453","volume":"19","author":"J Han","year":"2025","unstructured":"Han J et al (2025) The roles of microglia and astrocytes in neuroinflammation of Alzheimer\u2019s disease. Front Neurosci 19:1575453","journal-title":"Front Neurosci"},{"issue":"1","key":"5910_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.apsb.2025.10.018","volume":"16","author":"Y Wang","year":"2026","unstructured":"Wang Y, Zhang M, Li W (2026) Targeting glial cells: unveiling the neuroprotective mechanisms of ginseng in the brain microenvironment. Acta Pharm Sin B 16(1):13\u201334","journal-title":"Acta Pharm Sin B"},{"key":"5910_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ph18101529","author":"CE Hong","year":"2025","unstructured":"Hong CE, Lyu SY (2025) Immunomodulatory activities of emerging rare ginsenosides F1, Rg5, Rk1, Rh1, and Rg2: from molecular mechanisms to therapeutic applications. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph18101529","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"5910_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06615-6","volume":"7","author":"Y Zhu","year":"2024","unstructured":"Zhu Y et al (2024) Naringenin ameliorates amyloid-\u03b2 pathology and neuroinflammation in Alzheimer\u2019s disease. Commun Biol 7(1):912","journal-title":"Commun Biol"},{"key":"5910_CR62","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3389\/fphar.2020.00497","volume":"11","author":"S-Y Chen","year":"2020","unstructured":"Chen S-Y, Gao Y, Sun J-Y, Meng X-L, Yang D, Fan L-H et al (2020) Traditional Chinese medicine: role in reducing \u03b2-amyloid, apoptosis, autophagy, neuroinflammation, oxidative stress, and mitochondrial dysfunction of Alzheimer\u2019s disease. Front Pharmacol 11:497. https:\/\/doi.org\/10.3389\/fphar.2020.00497","journal-title":"Front Pharmacol"},{"issue":"12","key":"5910_CR63","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.3390\/app11125654","volume":"11","author":"M Park","year":"2021","unstructured":"Park M, Kim S-H, Lee H-J (2021) Ginsenoside Rh1 exerts neuroprotective effects by activating the PI3K\/Akt pathway in amyloid-\u03b2 induced SH-SY5Y cells. Appl Sci (Basel) 11(12):5654","journal-title":"Appl Sci (Basel)"},{"issue":"15","key":"5910_CR64","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/molecules24152687","volume":"24","author":"M Liu","year":"2019","unstructured":"Liu M et al (2019) Ginsenoside Re inhibits ROS\/ASK-1 dependent mitochondrial apoptosis pathway and activation of Nrf2-antioxidant response in beta-amyloid-challenged SH-SY5Y cells. Molecules (Basel) 24(15):2687","journal-title":"Molecules (Basel)"},{"issue":"9","key":"5910_CR65","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/biom12091310","volume":"12","author":"H Feng","year":"2022","unstructured":"Feng H et al (2022) Ginsenoside and its therapeutic potential for cognitive impairment. Biomolecules (Basel) 12(9):1310","journal-title":"Biomolecules (Basel)"},{"issue":"19","key":"5910_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911311","volume":"23","author":"Y-T Tsai","year":"2022","unstructured":"Tsai Y-T, Kao S-T, Cheng C-Y (2022) Medicinal herbs and their derived ingredients protect against cognitive decline in in vivo models of Alzheimer\u2019s disease. Int J Mol Sci 23(19):11311","journal-title":"Int J Mol Sci"},{"key":"5910_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-34689-7","author":"Q Huang","year":"2026","unstructured":"Huang Q et al (2026) Activation of M1mAChR\u2019s improves spatial learning and memory deficits in rats exposed to chronic intermittent hypoxia. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-025-34689-7","journal-title":"Sci Rep"},{"issue":"4","key":"5910_CR68","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jgr.2025.05.005","volume":"49","author":"H Iqbal","year":"2025","unstructured":"Iqbal H, Rhee DK (2025) The role of ginseng in aging: insights into regulatory T cells activation and mitochondrial regulation. J Ginseng Res 49(4):376\u2013388","journal-title":"J Ginseng Res"},{"issue":"12","key":"5910_CR69","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.3390\/ijms18122682","volume":"18","author":"J Yin","year":"2017","unstructured":"Yin J et al (2017) Study on the correlation between gene expression and enzyme activity of seven key enzymes and ginsenoside content in ginseng in over time in Ji\u2019an, China. Int J Mol Sci 18(12):2682","journal-title":"Int J Mol Sci"},{"key":"5910_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jep.2016.06.013","volume":"190","author":"RJ Choi","year":"2016","unstructured":"Choi RJ et al (2016) BACE1 molecular docking and anti-Alzheimer\u2019s disease activities of ginsenosides. J Ethnopharmacol 190:219\u2013230","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"5910_CR71","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/molecules23030589","volume":"23","author":"J-L Yang","year":"2018","unstructured":"Yang J-L et al (2018) Progress on the studies of the key enzymes of ginsenoside biosynthesis. Molecules (Basel) 23(3):589","journal-title":"Molecules (Basel)"},{"issue":"4","key":"5910_CR72","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4314\/ahs.v24i4.41","volume":"24","author":"X Ma","year":"2024","unstructured":"Ma X, Wang J (2024) Research progress on the role of ginsenoside Rd in central nervous system diseases. Afr Health Sci 24(4):325\u2013331","journal-title":"Afr Health Sci"},{"issue":"2","key":"5910_CR73","first-page":"397","volume":"12","author":"H Zhu","year":"2023","unstructured":"Zhu H et al (2023) Progress in the conversion of ginsenoside Rb1 into minor ginsenosides using \u03b2-glucosidases. Foods (Basel) 12(2):397","journal-title":"Foods (Basel)"},{"key":"5910_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24152687","author":"M Liu","year":"2019","unstructured":"Liu M et al (2019) Ginsenoside Re inhibits ROS\/ASK-1 dependent mitochondrial apoptosis pathway and activation of Nrf2-antioxidant response in beta-amyloid-challenged SH-SY5Y cells. Molecules. https:\/\/doi.org\/10.3390\/molecules24152687","journal-title":"Molecules"},{"issue":"4","key":"5910_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70131","volume":"13","author":"MS Hossain","year":"2025","unstructured":"Hossain MS, Hussain MH (2025) Multi-target drug design in Alzheimer\u2019s disease treatment: emerging technologies, advantages, challenges, and limitations. Pharmacol Res Perspect 13(4):e70131","journal-title":"Pharmacol Res Perspect"},{"issue":"4","key":"5910_CR76","doi-asserted-by":"publisher","first-page":"457","DOI":"10.5142\/jgr.2011.35.4.457","volume":"35","author":"JH Heo","year":"2011","unstructured":"Heo JH et al (2011) Improvement of cognitive deficit in Alzheimer\u2019s disease patients by long term treatment with korean red ginseng. J Ginseng Res 35(4):457\u2013461","journal-title":"J Ginseng Res"},{"issue":"8","key":"5910_CR77","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1468-1331.2008.02157.x","volume":"15","author":"JH Heo","year":"2008","unstructured":"Heo JH et al (2008) An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer\u2019s disease. Eur J Neurol 15(8):865\u20138","journal-title":"Eur J Neurol"},{"issue":"4","key":"5910_CR78","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1089\/acm.2015.0265","volume":"22","author":"JH Heo","year":"2016","unstructured":"Heo JH, Park MH, Lee JH (2016) Effect of Korean red ginseng on cognitive function and quantitative EEG in patients with Alzheimer\u2019s disease: a preliminary study. J Altern Complement Med 22(4):280\u2013285","journal-title":"J Altern Complement Med"},{"issue":"6","key":"5910_CR79","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1179\/1476830512Y.0000000027","volume":"15","author":"JH Heo","year":"2012","unstructured":"Heo JH et al (2012) Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer\u2019s disease. Nutr Neurosci 15(6):278\u201382","journal-title":"Nutr Neurosci"},{"issue":"3","key":"5910_CR80","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jgr.2024.02.002","volume":"48","author":"R Lee","year":"2024","unstructured":"Lee R et al (2024) Emerging evidence that ginseng components improve cognition in subjective memory impairment, mild cognitive impairment, and early Alzheimer\u2019s disease dementia. J Ginseng Res 48(3):245\u2013252","journal-title":"J Ginseng Res"},{"key":"5910_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/cells14191506","volume":"14","author":"X Shen","year":"2025","unstructured":"Shen X et al (2025) Tau-targeted therapeutic strategies: mechanistic targets, clinical pipelines, and analysis of failures. Cells 14:1506. https:\/\/doi.org\/10.3390\/cells14191506","journal-title":"Cells"},{"key":"5910_CR82","doi-asserted-by":"publisher","first-page":"92","DOI":"10.12793\/tcp.2019.27.3.92","volume":"27","author":"K-C Park","year":"2019","unstructured":"Park K-C et al (2019) Cognition enhancing effect of Panax ginsenin in Korean volunteers with mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial. Transl Clin Pharmacol 27:92","journal-title":"Transl Clin Pharmacol"},{"issue":"5","key":"5910_CR83","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2174\/1568026615666150813143753","volume":"16","author":"Y Wang","year":"2016","unstructured":"Wang Y et al (2016) Ginseng for Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized controlled trials. Curr Top Med Chem 16(5):529\u2013536","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"5910_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2021.100773","volume":"11","author":"WJ Lee","year":"2022","unstructured":"Lee WJ et al (2022) Safety and efficacy of dietary supplement (gintonin-enriched fraction from ginseng) in subjective memory impairment: a randomized placebo-controlled trial. Integr Med Res 11(1):100773","journal-title":"Integr Med Res"},{"issue":"6","key":"5910_CR85","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jgr.2023.06.005","volume":"47","author":"R Lee","year":"2023","unstructured":"Lee R et al (2023) Cognitive function improvement effects of gintonin-enriched fraction in subjective memory impairment: an assessor- and participant-blinded placebo-controlled study. J Ginseng Res 47(6):735\u2013742","journal-title":"J Ginseng Res"},{"key":"5910_CR86","doi-asserted-by":"publisher","first-page":"1268385","DOI":"10.3389\/fnagi.2023.1268385","volume":"15","author":"BC Lee","year":"2023","unstructured":"Lee BC, Lee DY, Seo EH, Choo IH, Kim JW, Kim SG et al (2023) Ginseng intake and Alzheimer disease-specific cognition in older adults according to apolipoprotein \u03b54 allele status. Front Aging Neurosci 15:1268385. https:\/\/doi.org\/10.3389\/fnagi.2023.1268385","journal-title":"Front Aging Neurosci"},{"key":"5910_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/nu16121952","author":"HI Baek","year":"2024","unstructured":"Baek HI et al (2024) Efficacy and safety of Panax ginseng sprout extract in subjective memory impairment: a randomized, double-blind, placebo-controlled clinical trial. Nutrients. https:\/\/doi.org\/10.3390\/nu16121952","journal-title":"Nutrients"},{"issue":"4","key":"5910_CR88","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/biom12040512","volume":"12","author":"X Song","year":"2022","unstructured":"Song X, Wang L, Fan D (2022) Insights into recent studies on biotransformation and pharmacological activities of ginsenoside Rd. Biomolecules 12(4):512","journal-title":"Biomolecules"},{"key":"5910_CR89","doi-asserted-by":"publisher","DOI":"10.1113\/EP093301","author":"AA Ghahari","year":"2026","unstructured":"Ghahari AA et al (2026) Psychobiotics and the microbiota-gut-brain axis: emerging paradigms in mental health modulation. Exp Physiol. https:\/\/doi.org\/10.1113\/EP093301","journal-title":"Exp Physiol"},{"issue":"11","key":"5910_CR90","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.3390\/pharmaceutics13111980","volume":"13","author":"R Whelan","year":"2021","unstructured":"Whelan R, Hargaden GC, Knox AJS (2021) Modulating the blood\u2013brain barrier: a comprehensive review. Pharmaceutics 13(11):1980","journal-title":"Pharmaceutics"},{"issue":"1","key":"5910_CR91","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/17425247.2024.2440099","volume":"22","author":"N Bhom","year":"2025","unstructured":"Bhom N et al (2025) Extracellular nanovesicles as neurotherapeutics for central nervous system disorders. Expert Opin Drug Deliv 22(1):69\u201384","journal-title":"Expert Opin Drug Deliv"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05910-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05910-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05910-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:02:05Z","timestamp":1778868125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05910-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5910"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05910-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Registration"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}],"article-number":"631"}}